[1]
“Evaluation of Interleukin – 12 and Interleukin – 23 expressions in patients with active and latent tuberculosis infection”, Journal of Pharmaceutical Negative Results, pp. 2148–2153, Nov. 2022, Accessed: Jun. 09, 2026. [Online]. Available: https://mail.pnrjournal.com/index.php/home/article/view/3436